NCT00778843
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
- Locations
-
- National Institute of Gastroenterology Vedado, La Habana, Cuba
Clinical trial condition
Blood-Borne Infections
Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.
8,270 public trials
443 recruiting studies
Blood-Borne Infections trial results
NCT00218712
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- UCSF AIDS Health Project San Francisco, California, United States
- SFDPH San Francisco City Clinic San Francisco, California, United States
NCT00381875
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
NCT00001035
- Conditions
- AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +21 more
- Locations
-
- USC CRS Los Angeles, California, United States
- Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
- NY Univ. HIV/AIDS CRS New York, United States
Completed
Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test
NCT01032902
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- Univeristy of California, San Diego La Jolla, California, United States
- Therafirst Fort Lauderdale, Florida, United States
- University of Maryland Baltimore, Maryland, United States
- St. Christopher's Hospital for Children/ Drexel University College of Medicine Philadelphia, Pennsylvania, United States
Completed
Dolutegravir Renal Impairment Study
NCT01353716
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Minneapolis, Minnesota, United States
NCT01203319
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified
NCT00098306
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- Pfizer Investigational Site Sacramento, California, United States
- Pfizer Investigational Site San Francisco, California, United States
- Pfizer Investigational Site San Francisco, California, United States
- Pfizer Investigational Site San Francisco, California, United States
NCT00851383
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- University of Rochester Medical Center Rochester, New York, United States
Completed
Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
NCT01010399
- Conditions
- Blood-Borne Infections, Communicable Diseases, Dyslipidemias, +18 more
- Locations
-
- Franco Felizarta, MD Bakersfield, California, United States